The elevated level of Granzyme b in the CD8a+ T cells (Fig. 7b) and the increased cellular killing seen by microscopy (Fig. 7c) further indicates that the CTL effector mechanisms have been heightened in the presence of ILC2s, providing a mechanism for ILC2 action in anti-cancer immunity. Here, CD8A is linked to cancer.